TipRanks
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market
NVCT
Nuvectis Pharma
RESEARCH TOOLSreports
Want to see NVCT full AI Analyst Report?

Nuvectis Pharma (NVCT) Stock News & Sentiment

138 Followers
Nuvectis Oncology Reaffirmed at Buy as Analyst Cites Differentiated BRAF Pipeline and Maintains $30 Price Target
Premium
Ratings
Nuvectis Oncology Reaffirmed at Buy as Analyst Cites Differentiated BRAF Pipeline and Maintains $30 Price Target
12d ago
NVCT
Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
Premium
TipRanks Newswire
Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
12d ago
AZN
NVS
Nuvectis: Buy Rating Reaffirmed as NXP Pipeline Progress and Regulatory Momentum Support Unchanged $39 Price Target
Premium
Ratings
Nuvectis: Buy Rating Reaffirmed as NXP Pipeline Progress and Regulatory Momentum Support Unchanged $39 Price Target
13d ago
NVCT
Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)
Premium
TipRanks Newswire
Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech (NASDAQ: NVCT)
1M ago
AZN
NVCT
Nuvectis Pharma Launches New $200 Million ATM Program
Premium
Company Announcements
Nuvectis Pharma Launches New $200 Million ATM Program
2M ago
8K
NVCT
Nuvectis’ NXP800 Ovarian Cancer Trial Terminated: What Investors Should Watch Next
Premium
Company Announcements
Nuvectis’ NXP800 Ovarian Cancer Trial Terminated: What Investors Should Watch Next
2M ago
NVCT
Nuvectis Pharma’s Heavy Reliance on Haisco Poses Major Operational and Geopolitical Risks
Premium
Company Announcements
Nuvectis Pharma’s Heavy Reliance on Haisco Poses Major Operational and Geopolitical Risks
2M ago
NVCT
More NVCT News >

NVCT News on the Web

Nuvectis Pharma files $200M mixed securities shelf
TipRanks News
Neutral
Nuvectis Pharma Launches New $200 Million ATM Program
TipRanks News
Neutral
Nuvectis Pharma’s Heavy Reliance on Haisco Poses Major Operational and Geopolitical Risks
TipRanks News
Bearish
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
TipRanks News
Neutral
Nuvectis Pharma price target raised to $33 from $20 at Roth Capital
TipRanks News
Bullish
Insider Buying: Ron Bentsur Acquires Additional Shares of Nuvectis Pharma Inc (NVCT)
GuruFocus News
Bullish
Nuvectis Pharma Announces Major Public Equity Offering
TipRanks News
Neutral
Closing Bell Movers: AeroVironment jumps after quarterly report
TipRanks News
Bearish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average1.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NVCT’s Media Buzz Sentiment?
Currently, no data Available
What is NVCT’s weekly average amount of articles?
In an average week, 1.25 articles about NVCT are published.
    What is NVCT’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    REGNRegeneron
    QTTBQ32 Bio
    NVSNovartis
    RHHVFRoche Holding AG
    KRROKorro Bio
    Showing the stocks with the most bullish news sentiment over the past week